Chronic lung disease · preterm infants
It is very uncertain whether lower changes chronic lung disease (36 weeks' corrected age) compared with higher oxygen concentrations titrated to target oxygen saturations… (very low certainty).
1 finding from 1 review
Intervention not reported
Breathlessness ‐ all trials Lower score indicates improvement in breathlessness · patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
1 finding from 1 review
Intervention not reported
Breathlessness ‐ subgroup analysis ‐ studies measuring during exercise test Lower score indicates improvement in breathlessness · patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
1 finding from 1 review
Intervention not reported
Breathlessness ‐ subgroup analysis ‐ studies not measuring during exercise test Lower score indicates improvement in breathlessness · patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
1 finding from 1 review
Intervention not reported
Health‐related quality of life ‐ all trials Higher scores indicate improved health‐related quality of life · patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
1 finding from 1 review
Intervention not reported
Exercise capacity (5‐ or 6‐minute walking distance on cylinder air) · adults with COPD who had exertional dyspnoea but did not fulfil the criteria for long‐term oxygen treatment
1 finding from 1 review
Intervention not reported
Mortality · adults with COPD who had exertional dyspnoea but did not fulfil the criteria for long‐term oxygen treatment
The intervention showed no clear difference in mortality (moderate certainty).
1 finding from 1 review
Intervention not reported
Quality of life (dyspnoea) Measured on the CRQ, the output is a number from 0 to 7, where higher on the scale is better. MID is 0.5. · adults with COPD who had exertional dyspnoea but did not fulfil the criteria for long‐term oxygen treatment
The intervention probably leads to higher quality of life (dyspnoea) Measured on the CRQ, the output is a… (moderate certainty).
1 finding from 1 review
Intervention not reported
Dyspnoea · adults with COPD who had exertional dyspnoea but did not fulfil the criteria for long‐term oxygen treatment
1 finding from 1 review
Intervention not reported
Adverse events · adults with COPD who had exertional dyspnoea but did not fulfil the criteria for long‐term oxygen treatment
The intervention showed no clear difference in adverse events (low certainty).
1 finding from 1 review
Intervention not reported
Hospitalisations · adults with COPD who had exertional dyspnoea but did not fulfil the criteria for long‐term oxygen treatment
1 finding from 1 review
Length of hospital stay · infants with bronchiolitis
1 finding from 1 review
Adverse events · infants with bronchiolitis
Summary of findings table ‐ High‐flow nasal cannula showed no clear difference in adverse events compared with standard oxygen therapy (low‐flow) (low certainty).
1 finding from 1 review
Change in respiratory rate at 20 minutes · infants with bronchiolitis
1 finding from 1 review
Change** in heart rate (beats/min) · infants with bronchiolitis
1 finding from 1 review
Need for treatment escalation · infants with bronchiolitis
Summary of findings table ‐ High‐flow nasal cannula probably leads to lower need for treatment escalation compared with standard oxygen therapy (low‐flow) (moderate certainty).
1 finding from 1 review
Change in croup score. · children with croup
1 finding from 1 review
Change in respiratory rate at 20 minutes · children with croup
1 finding from 1 review
Heart rate · children with croup
1 finding from 1 review
Proportion of children hospitalised · children with croup
The review found no eligible studies for this question.
1 finding from 1 review